2b0u
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="2b0u" size="450" color="white" frame="true" align="right" spinBox="true" caption="2b0u, resolution 2.800Å" /> '''The Structure of t...)
Next diff →
Revision as of 18:50, 12 November 2007
|
The Structure of the Follistatin:Activin Complex
Contents |
Overview
TGF-beta ligands stimulate diverse cellular differentiation and growth, responses by signaling through type I and II receptors. Ligand, antagonists, such as follistatin, block signaling and are essential, regulators of physiological responses. Here we report the structure of, activin A, a TGF-beta ligand, bound to the high-affinity antagonist, follistatin. Two follistatin molecules encircle activin, neutralizing the, ligand by burying one-third of its residues and its receptor binding, sites. Previous studies have suggested that type I receptor binding would, not be blocked by follistatin, but the crystal structure reveals that the, follistatin N-terminal domain has an unexpected fold that mimics a, universal type I receptor motif and occupies this receptor binding site., The formation of follistatin:BMP:type I receptor complexes can be, explained by the stoichiometric and geometric arrangement of the, activin:follistatin complex. The mode of ligand binding by follistatin has, important implications for its ability to neutralize homo- and, heterodimeric ligands of this growth factor family.
Disease
Known disease associated with this structure: Polycystic ovary syndrome OMIM:[136470]
About this Structure
2B0U is a Protein complex structure of sequences from Homo sapiens with IR3, MLI and MPD as ligands. Full crystallographic information is available from OCA.
Reference
The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding., Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS, Dev Cell. 2005 Oct;9(4):535-43. PMID:16198295
Page seeded by OCA on Mon Nov 12 20:56:54 2007
Categories: Homo sapiens | Protein complex | Cook, R.W. | Jardetzky, T.S. | Lerch, T.F. | Thompson, T.B. | Woodruff, T.K. | IR3 | MLI | MPD | Activin | Follistatin | Inhibin | Morphogen | Tgf-beta